- Investigators
- Carmen Isache, Jorge L Verdecia
- Ages
- 18 Years - 80 Years
- Sexes
- All
Clinical trials
-
RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) -
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
ReMEDy2: A Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke - Investigators
- Benjamin T Alwood, Scott L Silliman
- Ages
- 18 Years - 90 Years
- Sexes
- All
-
Study of BD ORC Original Absorbable Hemostat Compared with Surgicel庐 Original Absorbable Hemostat - Investigator
- Kethandapatti Balaji
- Ages
- 22 Years - 101 Years
- Sexes
- All
-
A Natural History and Outcome Measure Discovery Study of PRPF31 Mutation鈥揂ssociated Retinal Dystrophy (20226317) - Investigator
- Sandeep Grover
- Ages
- N/A
- Sexes
- All
-
Study of BD ORC Original Absorbable Hemostat vs. Surgicel庐 Original Absorbable Hemostat - Investigators
- Shane Hester, Ruchir Puri, Jana M Sacco
- Ages
- 22 Years - 99 Years
- Sexes
- All
-
Real-time and long-term effects of medical marijuana on older adults with chronic pain; A prospective cohort study - Ages
- 50 Years - N/A
- Sexes
- All
-
A Study of the Efficacy and Safety of Treatment With MNKD-101 When Added to GBT in Participants with Pulmonary Nontuberculous Mycobacterial Infection - Ages
- 18 Years - 85 Years
- Sexes
- All
-
BHV7000-304: A Phase 2/3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 - Investigators
- Ramon E Bautista, Suparna R Krishnaiengar, Katherine A Zarroli
- Ages
- 18 Years - 75 Years
- Sexes
- All